Parental height, target height, and age at puberty onset of subjects with VLBW who were included in the extended analyses.

<p>Data are expressed as the mean (SD) or <i>n</i> (%).</p><p>*<i>P</i> values are shown for the comparison between males and females.</p>†<p>Below the target height and <10th percentile.</p><p>Parental height, target height, and age at puberty onset of subjects with VLBW who were included in the extended analyses.</p

Associations between final height and cardiometabolic outcomes in young adults with VLBW in the primary and extended analyses.

<p>*Associations were adjusted for sex, body weight, family history of diabetes, and SGA/AGA.</p>†<p>Associations were adjusted for sex, body weight, family history of diabetes, SGA/AGA, target height, and age at puberty onset.</p>‡<p>Measured during 75-g oral glucose tolerance tests.</p>§<p>eGFR = 194×Cre^−1.094× Age^−0.287 (×0.739 for females).</p><p>AGA, appropriate for gestational age; CI, confidence interval; eGFR, estimated glomerular filtration rate; fT4, free T4; SGA, small for gestational age; TSH, thyroid stimulating hormone.</p><p>Associations between final height and cardiometabolic outcomes in young adults with VLBW in the primary and extended analyses.</p

Subject disposition.

<p>Subject disposition.</p